Skip to main content
. Author manuscript; available in PMC: 2020 Jun 10.
Published in final edited form as: Trends Analyt Chem. 2018 Nov 24;120:115322. doi: 10.1016/j.trac.2018.11.020

Figure 5. Metabolism and epigenetic regulation.

Figure 5.

The diagram depicts 13C tracing from 13C6-glucose (Inline graphic) or 13C/15N tracing from 13C5,15N2 glutamine (Inline graphic) to the synthesis of nucleotides and effectors (dark red text) involved in epigenetic modifications, including αketoglutarate (αKG), 2-hydroxyglutarate (2HG), succinate, and fumarate. IDH1/2 mutants produce the histone demethylation inhibitor 2HG from αKG while inactivating SDH and FH mutations generate high levels of succinate and fumarate, which are inhibitors of αKG-dependent dioxygenases including TET involved in demethylation of methylcytosine in DNA. Green arrows denote anaplerotic inputs into the Krebs cycle mediated by pyruvate carboxylase (PCB) (Inline graphic) and glutaminase (GLS) reactions. { } encloses scrambled 13C labeling patterns of succinate, fumarate, malate, and Asp after one turn of the Krebs cycle. ●: 12C; OAA: oxaloacetate; HK: hexokinase; G6PDH: glucose-6-phosphate dehydrogenase; PDH: pyruvate dehydrogenase; IDHm: isocitrate dehydrogenase mutant; PUR: purine synthesis; PYR: pyrimidine synthesis; PPP: pentose phosphate pathway; 1-C: one-carbon pathway; exo: exocyclic.